DS
EIGR
DRW Securities’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-120,365
| Closed | -$37K | – | 409 |
|
|
2023
Q3 | $37K | Hold |
120,365
| – | – | ﹤0.01% | 258 |
|
|
2023
Q2 | $85K | Hold |
120,365
| – | – | ﹤0.01% | 234 |
|
|
2023
Q1 | $108K | Hold |
120,365
| – | – | ﹤0.01% | 214 |
|
|
2022
Q4 | $142K | Hold |
120,365
| – | – | ﹤0.01% | 162 |
|
|
2022
Q3 | $906K | Hold |
120,365
| – | – | 0.02% | 57 |
|
|
2022
Q2 | $758K | Hold |
120,365
| – | – | 0.02% | 64 |
|
|
2022
Q1 | $999K | Hold |
120,365
| – | – | 0.03% | 59 |
|
|
2021
Q4 | $625K | Hold |
120,365
| – | – | 0.02% | 62 |
|
|
2021
Q3 | $804K | Hold |
120,365
| – | – | 0.03% | 61 |
|
|
2021
Q2 | $1.03M | Hold |
120,365
| – | – | 0.03% | 66 |
|
|
2021
Q1 | $1.07M | Hold |
120,365
| – | – | 0.04% | 44 |
|
|
2020
Q4 | $1.48M | Sell |
120,365
-30,000
| -20% | -$369K | 0.05% | 45 |
|
|
2020
Q3 | $1.22M | Buy |
150,365
+40,000
| +36% | +$326K | 0.07% | 44 |
|
|
2020
Q2 | $1.06M | Hold |
110,365
| – | – | 0.05% | 52 |
|
|
2020
Q1 | $750K | Hold |
110,365
| – | – | 0.03% | 84 |
|
|
2019
Q4 | $1.64M | Hold |
110,365
| – | – | 0.06% | 46 |
|
|
2019
Q3 | $1.13M | Buy |
110,365
+40,365
| +58% | +$414K | 0.08% | 52 |
|
|
2019
Q2 | $742K | Buy |
+70,000
| New | +$742K | 0.04% | 41 |
|
|
2019
Q1 | – | Sell |
-24,752
| Closed | -$251K | – | 105 |
|
|
2018
Q4 | $251K | Buy |
24,752
+10,000
| +68% | +$101K | 0.01% | 38 |
|
|
2018
Q3 | $177K | Sell |
14,752
-4,348
| -23% | -$52.2K | 0.01% | 31 |
|
|
2018
Q2 | $233K | Buy |
19,100
+3,100
| +19% | +$37.8K | 0.01% | 47 |
|
|
2018
Q1 | $158K | Buy |
+16,000
| New | +$158K | 0.01% | 109 |
|